Diabetes

inltv.com  INLNews.Com au1.us for DailyworldnewsHeadlines  USA MAIL
USAWeeklyNewsNews Easy To find Hard To Leave EdinburghFringeFest   USAWeekendNews
YahooMail HotMail GMail MyWayMail  AOLMail   INLNs   CNNWorld  IsraelVideoNs NYTimes WashNs WorldMedia  JapaNs  AusNs WorldVideoNs  WorldFinance ChinaDaily  IndiaNs
USADaily BBC EuroNs ABCAust NZNews QldNews WANs   NZNews  QldNews  MelbAge
AdeaideNews  TasNews  ABCTas  DarwinN Top Stories Video/Audio  Reuters AP AFP The Christian Science Monitor U.S. News & World Report AFP Features Reuters Life! NPR The Advocate Pew Daily Number Today in History Obituaries Corrections Politics   LocalNews o BBC News Video Reuters Video AFP Video CNBC Video Australia 7 News Video CBC.ca Video  NPR Audio Kevin Sites in the Hot Zone Video Richard Bangs Adventures Video Charlie Rose Video Expanded Books Video Assignment Earth Video ROOFTOPCOMEDY.com Video Guinness World Records Video weather.com
Video AccuWeather Video You Witness News User VideoNews Services News via RSS  News Alerts Weather Alerts News Badge Yahoo! News Help
News by Region (Yahoo! Directory) News & Media Sites (Yahoo! Directory)

INLTV.com YourWorldNews

Diabetes_News

USA WEEKLY NEWS EASY TO FIND HARD TO LEAVE
Visit International News Limited for the best values on:
domain names-domain transfers
INLNews YahooMail HotMail GMail AOLMail USA MAIL
HottestWebNews
Twitter http://twitter.com/following
Comcast.net: News, Sports, Video, TV listings, Email and more!http://www.comcast.net/d/
www.facebook.com
Facebook is a social utility that connects people with friends and others who work, study and live around them. People use Facebook to keep up with friends,
http://www.facebook.com/login.php
www.myspace.com/fringeshowshavetalent for entertaining fringe video clips
USA WEEKLY NEWS EASY TO FIND HARD TO LEAVE
Visit International News Limited for the best values on:
domain names-domain transfers
INLNews YahooMail HotMail GMail AOLMail USA MAIL

Click here to get you daily dose of Real Independent USA News with Amy Goodman at Domocracy Now

A daily TV/radio news program, hosted by Amy Goodman and Juan Gonzalez, airing on over 750 stations,
pioneering the largest community media collaboration in the U.S.http://www.democracynow.org

http://www.huffingtonpost.com/

GamingHarbor, Download Games to get 1000’s of Games!

http://www.gamingharbor.com/go.do?a=1805&l=4019

Welcome to Gaia | Gaia Onlinehttp://www.gaiaonline.com/

The Official Site of Major League Baseball: Events: 2009 All-Star Game Sprint Final Vote

http://mlb.mlb.com/mlb/events/all_star/y2009/fv/ballot.html

Make Money At Home Onlinehttp://www.howimadecash.com/a/

Read Free Manga Online at One Manga. Online manga scans reader.http://www.onemanga.com/

www.world-job-news.com http://www.world-job-news.com/finance/?t202id=89559&t202kw=lppop-1

Mozilla Firefox Start Pagehttp://www.google.com/firefox?client=firefox-a&rls=org.mozilla:en-US:o...

Inspirational Quote "The beginning of love is to let those we love be perfectly themselves, and not to twist them to fit our own image. Otherwise we love only the reflection of ourselves we find in them.? Thomas Merton"

http://www.google.com/firefox?client=firefox-a&rls=org.mozilla:en-US:o...

Your Daily Motivation from Inspiration Line Add Inspiring Daily Quotes to YOUR Website

Click Here For Your Up To Date World Live Sports Scores
INLNews  YahooMail  HotMail  GMail   AOLMail USA MAILMyWayMail
CNNWorld IsraelVideoNs INLNs NYTimes WashNs WorldMedia JapanNs AusNs World VideoNs WorldFinance ChinaDaily IndiaNs USADaily BBC EuroNs ABCAust
WANs NZNews QldNs MelbAge AdelaideNs
TasNews ABCTas DarwinNs USA MAIL

ABC News Video   FOX News Video   FOXBusiness Video   CNN Video   AP Video   BBC News Video   Reuters Video   AFP Video   CNET Video
CNBC Video   Australia 7 News Video    Rocky Mountain News Elections Video   CBC.ca Video   NPR Audio
Kevin Sites in the Hot Zone Video
Richard Bangs Adventures Video   Charlie Rose Video    Expanded Books Video   Assignment Earth Video
ROOFTOPCOMEDY.com Video
Guinness World Records Video   weather.com Video   AccuWeather Video   You Witness News User Video

NPR Audio BY CATEGORY Top Stories Politics World Business Sports
Technology Health & Science Arts U.S.

VIEW LOCAL VIDEO KVUE-TV Austin   WJZ 13 Baltimore   WBZ Boston
WCNC Charlotte   CBS 2 Chicago
CBS 11 Dallas   CBS4 Denver   13 News, WVEC Hampton Roads   11 News Houston
CBS 2 / KCAL 9 Los Angeles

WHAS TV11 Louisville   CBS4 Miami   WCCO Minneapolis   WWL-TV,
Channel 4 New Orleans   CBS 2 New York

CBS 3 Philadelphia KTVK 3TV Phoenix   KDKA Pittsburgh
KGW NewsChannel 8 Portland, Ore.  WRAL.com Raleigh

CBS 13 / CW 31 Sacramento   KENS 5 - TV San Antonio   Channel 8 San Diego
CBS 5 San Francisco

KING5 Seattle   KREM.com Spokane/Coeur d'Alene   KMOV
Channel 4 St. Louis   FOX 11 Tucson

Video by Category
U.S. Business World Entertainment Sports Tech Politics Science
Health Environment Weather Opinion Odd

Video by Topic Campaign '08 Wall Street Iraq Gas Prices Mideast Conflict
Climate Change

Diabetes Diagnosis

Diagnosis for both type 1 and type 2 diabetes can occur in a number of different ways.
www.diabetes.co.uk/Diabetes-diagnosis.html

Diabetes Search Results for Diabetes Uk

Diabetes.co.uk. Web. Diabetes Products. Desang Kitbags · Medi-Tag Jewellery · Zsweet - Natural Sweetener · See all products. Share Us ...
www.diabetes.co.uk/results.asp?q=diabetes+UK&client=google-csbe&cx=007373116414207289069:bexng2zwcby&cof=FORID:11

Exercise for Diabetics

People with diabetes are encouraged to exercise regularly for better blood sugar control and to reduce the risk of cardiovascular diseases.
www.diabetes.co.uk/exercise-for-diabetics.html

Diabetes & Diabetic News, Updated Daily

Diabetes news updated daily regarding all aspects of diabetes, including diabetes drugs, research, breakthroughs, illnesses, companies and other information ...
www.diabetes.co.uk/news/index.html

People with diabetes not getting psychological support

Apr 8, 2009 ... According to the leading health charity Diabetes UK, as many as 85 per cent of adults suffering from diabetes in the UK are lacking access ...
www.diabetes.co.uk/news/2009/Apr/people-with-diabetes-not-getting-psychological-support.html

Diabetes Forum • The Global Diabetes Community

This forum is the centre of the new community section of Diabetes.co.uk. Meet here to discuss diabetes issues, get help about diabetes, meet other diabetics ...
www.diabetes.co.uk/diabetes-forum/

DVLA facing petition about diabetes stance

Apr 30, 2009 ... The Driving and Vehicle Licensing Authority is facing a petition about its stance on diabetes . A petition has been issued calling for the ...
www.diabetes.co.uk/news/2009/Apr/dvla-facing-petition-about-diabetes-stance.html

Diabetes UK Careline - Contact Careline Scotland

Diabetes UK, the leading UK diabetes charity, offers a unique service known as theDiabetes UK Careline. This is a service provided by Diabetes.org.uk, ...
www.diabetes.co.uk/diabetes-uk-careline.html

Treatment for Diabetes

Successful treatment makes all the difference to long-term health, and achieving balanceddiabetes treatment can be the key to living with both type 1 and ...
www.diabetes.co.uk/treatment.html

Blood Sugar Glucose Converter for Diabetes

Convert blood sugar/glucose from mmol/L (UK standard) to mg/dl (US standard) and vice versa using our blood sugar converter.
www.diabetes.co.uk/blood-sugar-converter.html

About Us - Diabetes.co.uk

Diabetes.co.uk is part of the SFN Network of websites, based in the heart of England.Diabetes.co.uk has grown over the past 3 years into a vast diabetes ...
www.diabetes.co.uk/about.html

Diabetes UK Charity

Diabetes UK is the UK's leading diabetes charity, celebrating its 75th anniversary this year. Founded in 1934, Diabetes UK has over 170000 members and works ...
www.diabetes.co.uk/diabetes-charity/diabetes-uk.html

Diabetes Help & Support

Diabetes.co.uk is here to help and support diabetics and those affected by diabetes. This is a free, community-led information and support resource for ...
www.diabetes.co.uk/diabetes-help.html

Contact Diabetes.co.uk

Contact the team at Diabetes.co.uk, based in Coventry, England.
www.diabetes.co.uk/contact.html

Diabetes Test Strips

Blood glucose test strips (diabetes test strips) are one of the components of a diabetesmonitoring system. Diabetic test strips are an essential part of ...
www.diabetes.co.uk/diabetes_care/diabetes-test-strips.html

Insulin in the UK

Insulin may be a key part of your treatment if you suffer from Diabetes. Insulin enables your body to use glucose. Different types of insulin can act very ...
www.diabetes.co.uk/insulin-in-the-uk.html

Diabetes Charity Directory - Donate Online to UK & US Diabetes ...

Diabetes.co.uk aims to give its visitors the chance to learn more about individualdiabetes charities in the UK and US and what they do.
www.diabetes.co.uk/diabetes-charities.html

Diabetes UK release new viral film

Sep 18, 2008 ... The Leading UK diabetes charity has taken a novel approach to spreading the message about type 1 diabetes . Available both online and via ...
www.diabetes.co.uk/news/2008/Sep/diabetes-uk-release-new-viral-film.html

Diabetes Forum • Your chance to tell Diabetes UK what you want!

Diabetes UK produces information for young people like you about how to look after yourdiabetes and how to fit it into your daily life. ...
www.diabetes.co.uk/diabetes-forum/viewtopic.php?f=16&t=6884

UK Diabetes Industry

UK diabetes companies - A directory of major UK diabetes companies, diabetes business and pharmaceutical companies, the diabetes industry.
www.diabetes.co.uk/diabetes-industries.html

Useful Links - Diabetes.co.uk

This section of diabetes.co.uk aims to provide a resource for diabetic patients who are interested in finding out more about their condition online.
www.diabetes.co.uk/links.html

Diabetes UK in Second Life

Oct 24, 2008 ... The leading UK diabetes charity, Diabetes UK, have launched their new Silent Assassin campaign in Second Life. Second Life is a virtual ...
www.diabetes.co.uk/news/2008/Oct/diabetes-uk-in-second-life.html

Diabetes UK launch new campaign

Leading UK diabetes charity, Diabetes UK, has launched a fresh new hard-hitting UK diabetes campaign. The advertising campaign, called Silent Assassin, ...
www.diabetes.co.uk/news/2008/Oct/Diabetes-UK-launch-new-campaign.html

Glossary - A

ABPS, acronym for American Board of Podiatric Surgery Certification.
www.diabetes.co.uk/glossary/a.html

New chairman for Diabetes UK

Diabetes news this morning carries reports that emergency care tsar of the government will take the helm of diabetes charity Diabetes UK .
www.diabetes.co.uk/news/2009/Feb/New-chairman-for-Diabetes-UK.html

Diabetes And Stem Cell Research

Understanding the root causes of diabetes has eluded researchers for many years now. The way in which the immune system causes the destruction of precious ...
www.diabetes.co.uk/Diabetes-And-Stem-Cell-Research.html

DiabetesAction.org
http://www.diabetesaction.org/site/PageNavigator/Tips/tip

All diabetes questions are answered by Jane DeVane, MS, RD, CDE,
a Registered Dietician with a degree in exercise physiology and a certification in diabetes education. Her focus is an integrative approach to healing including management of diabetes, autoimmune and chronic conditions.
Heathly Recepies from DiabetesAction.org

Main / Side Dishes

Desserts, Snacks and other Treats

Soups and Salads

Thanksgiving Recipes

Enjoy these recipes that are not only delicious but
also especially healthy for people with diabetes.

See bottom of this page for more copies of these healthy recipiesor click here http://www.diabetesaction.org/site/PageServer?pagename=recipe

Versatile Vegetable Corn Muffins

You can use various vegetables to make these muffins both moist and lower in fat.

1 cup whole wheat flour
1 cup cornmeal
4 tsp. baking powder
1/4 cup sugar
1/2 tsp. salt
1 egg
1/2 cup skim milk or soymilk
2 Tbsp. canola oil
1/2 cup of one of the following fresh, frozen, or canned vegetables that has been cooked and mashed: butternut squash, sweet potato, pumpkin, zucchini, or spinach.

Preheat oven to 400 degrees.

Grease 12 cup muffin tin with non-stick cooking spray.

Mix together dry ingredients in a medium bowl.

Mix together wet ingredients in a small bowl. Add to the dry mixture and stir until just blended.

Pour mixture into muffin tin, filling cups 3/4 full.

Bake for 20 to 25 minutes.

Per muffin:
Makes 12 muffins

calories - 120
carbohydrate - 20 g
protein - 3 g
fiber - 2 g
fat - 3 g

Lentil Barley Stew

A bowl of this stew satisfies hunger and helps stabilize blood sugar levels. It is also high in protein and water soluble fiber.

8 cups water
1 cup dry lentils
1/2 cup pearl barley
2 carrots, scrubbed and cut into large chunks
2 stalks celery, chopped
1 large yellow onion, chopped
1 clove garlic, pressed or chopped fine
2 bay leaves
2 1/2 tsp. ground cumin
1 1/2 tsp. ground thyme
1 1/2 tsp. salt
1/2 tsp. cinnamon
1/4 tsp. black pepper

Combine all ingredients in a large heavy stew pot.

Cover and simmer for about 1 1/2 hours over low heat, stirring occasionally.

Adjust seasonings to suit your taste.

Makes 4 servings
Per serving:

270 calories

50 g carbohydrate

20 g fiber

0 g fat

16 g protein

Mixed Vegetable Stir-Fry

1 tablespoon sesame oil
2 teaspoons finely chopped ginger root
1/2 teaspoon finely chopped garlic
1 1/2 cups small broccoli flowerets
1 cup thinly sliced carrots
1 small onion, chopped
3/4 cup vegetable broth
1 tablespoon cornstarch
1 tablespoon cold water
1 can (8 ounces) sliced water chestnuts, drained
1 cup sliced mushrooms (about 3 ounces)
2 tablespoons oyster sauce

Heat sesame oil in wok or large skillet until hot. Add ginger root and garlic. Stir-fry about 1 minute or until light brown. Add broccoli, carrots and onion; stir-fry 1 minute. Stir in vegetable broth. Cover and cook about 3 minutes or until carrots are tender.

Mix cornstarch and cold water; stir into vegetable mixture. Cook and stir about 10 seconds or until thickened. Add water chestnuts, mushrooms and oyster sauce. Cook and stir 30 seconds.

Serve over brown rice or whole grain noodles if desired.

Makes 4 servings

Per serving (without rice or noodles):

95 calories
3 g protein
18 g carbohydrate
1 g fat
4 g fiber

Roasted Pumpkin Seeds

This crunchy snack is so easy and delicious there's no need to only make them at Halloween! Pumpkin seeds are a great source of magnesium, iron, zinc, essential fatty acids, and protein. They are also low in carbohydrate.

2 cups whole raw pumpkin seeds
1 tablespoon melted butter or oil
salt to taste

Scrape seeds from the inside of a pumpkin. Rinse the pumpkin pulp off as well as you can and pat dry.

Preheat oven to 150 degrees F (75 degrees C). Roasting on this lower heat helps to maintain more of the healthy essential fatty acids.

Combine all ingredients in bowl; stir to coat all the seeds.

Spread the seeds in a single layer on a baking sheet. Bake until seeds are golden brown (about 20 minutes), stirring occasionally.

Adjust seasonings to suit your taste. Experiment: try adding a bit of brown sugar for sweet and salty seeds or paprika and celery salt for a spicy batch.

Makes 4 servings
Per 1/4 cup serving:

186 calories

6 g carbohydrate

1.5 g fiber

15 g fat

8 g protein

Baked Spinach

Ingredients:

1 Tbsp butter
1/2 cup chopped onions
2 - 10oz. packages of frozen chopped spinach (thawed & drained)
2 Tbsp parmesan cheese
3/4 cup low fat ricotta cheese
1/4 tsp. ground nutmeg
1/8 tsp garlic powder
salt and pepper (to taste)
1 - 8 oz can tomato sauce
1/2 tsp. dried oregano
1/2 tsp. dried basil

Directions:

Melt butter in a large skillet over medium-high heat. Add onions and sauté until golden. Remove from heat.

Stir in spinach, parmesan cheese, ricotta cheese, nutmeg, garlic powder, salt and pepper.

Spoon into a 9-inch pie pan that has been sprayed with non-stick cooking spray.

Combine tomato sauce, oregano and basil. Spread evenly over spinach mixture.

Bake uncovered at 350 for 25 minutes.

Let stand for 5 minutes before serving.

Makes 4 servings
Per serving:

195 calories
14 g protein
15 g carbohydrate
10 g fat

Taiwanese Biotechnology Firm Introduces Possible Solution To Glucose Tolerance Lack Among Type II Diabetics
http://www.vitabeat.com/taiwanese-biotechnology-firm-introduces-possible-solution-to-glucose-tolerance-lack-among-type-ii-diabetics/v/7710/

A Taiwanese biotechnology company is bringing into the Philippines a possible solution for the glucose tolerance factor lack among Type II diabetics. Tainan-based Maxluck Biotechnology is launching on Thursday the GT and F milk, which helps human cells absorb glucose.

Dr. Frank Mao Chia Hung of Maxluck Biotechnology Corporation explained contrary to common belief that diabetes is an ailment, it is more the inability of the glucose to enter the cells rather than the failure of the pancreas to produce insulin. Using biotechnology he invented an element called trivalent chromium, which helps the glucose enter the cell and be converted as energy, instead of remaining in the blood and causing high blood sugar among Type II diabetics.

Trivalent chromium mimics the action of colostrum, found in mother's milk. Colostrum has large amounts of antibodies that protects the baby's vital body parts and plays a major role in producing chemical reactions to maintain life, including the conversion of glucose into energy. But since mother's milk is not available except for her newborn, Mao tapped biotechnology to come up with trivalent chromium.

Initially, Maxluck manufactured it as milk powder, but because of complaints by some diabetics of lactose intolerance, the company produced a second generation of trivalent chromium in capsule form.

Aside from helping Type II diabetics reduce their dependence on oral medication which often has side effects, trivalent chromium has been proven to help obese diabetics deal with their weight problems.

The GTF products are expected to be accepted widely by Filipinos, many of whom are prone to diabetes because of genetic predisposition and the Filipino diet that is high in sugar and fat contents. Worldwide, there are 250 million diabetics, expected to double within the next 30 years, Mao said.

RELATED HEALTH INFORMATION

German Gastroenterologists: Chewing Too Much Gum Causes Chronic Diarrhea Leading To Potentially Dangerous Weight Loss

Minnesota Meatpacker Recalls 188,000 Lbs. Beef Patties Tainted With E. Coli

Minor Leg Injuries Increase Blood Clot Risk

Genetically Modified Carrot Helps Body Absorb More Calcium

Study: Calcium Supplements May Raise Postmenopausal Heart Risk

Mexico To Overtake U.S. In Obesity Incidents By 2018

Diabetes effects millions of people in the world and is an important subject to keep in public discussions and blogs...and is the subject of new research involving potential treatment of diabetes that could help millions of people live a more fullfulling life..

What Wikipedia has to say on Diabetes
diabetes in cats and dogs.

Diabetes mellitus (, often referred to simply as diabetes compass, dividers stemming from the verb "to pass through", consisting of the prefix da dia across, through and the verb to go, to walk) , is a syndrome of disordered metabolism, usually due to a combination of hereditary and environmental causes, resulting in abnormally high blood sugar levels (hyperglycemia).^[2] Diabetes affects aproximately 18,000,000 children and adults in the United States, and perhaps 420,000,000 persons worldwide. Many millions of persons have diabetes but have not yet been diagnosed. Blood glucose levels are controlled by a complex interaction of multiple chemicals and hormones in the body, including the hormone insulin made in the beta cells of the pancreas. Diabetes mellitus refers to the group of diseases that lead to high blood glucose levels due to defects in either insulin secretion or insulin action in the body.^[3]

Diabetes develops due to a diminished production of insulin (in type 1) or resistance to its effects (in type 2 and gestational).^[4] Both lead to hyperglycemia, which largely causes the acute signs of diabetes: excessive urine production, resulting compensatory thirst and increased fluid intake, blurred vision, unexplained weight loss, lethargy, and changes in energy metabolism.

All forms of diabetes have been treatable since insulin became medically available in 1921, but there is no cure. The injections by asyringe, insulin pump, or insulin pen deliver insulin, which is a basic treatment of type 1 diabetes. Type 2 is managed with a combination of dietary treatment, exercise, medications and insulin supplementation.

Diabetes and its treatments can cause many complications. Acute complications including hypoglycemia, ketoacidosis, ornonketotic hyperosmolar coma may occur if the disease is not adequately controlled. Serious long-term complications includecardiovascular disease, chronic renal failure, retinal damage, which can lead to blindness, several types of nerve damage, and microvascular damage, which may cause erectile dysfunction and poor wound healing. Poor healing of wounds, particularly of the feet, can lead to gangrene, and possibly to amputation. Adequate treatment of diabetes, as well as increased emphasis on blood pressure control and lifestyle factors such as not smoking and maintaining a healthy body weight, may improve the risk profile of most of the chronic complications. In the developed world, diabetes is the most significant cause of adult blindness in the non-elderly and the leading cause of non-traumatic amputation in adults, and diabetic nephropathy is the main illness requiring renal dialysis in the United States.^[5]

^{Classification}

The term diabetes, without qualification, usually refers to diabetes mellitus, which is associated with excessive sweet urine (known as "glycosuria") but there are several rarer conditions also named diabetes. The most common of these is diabetes insipidus in which the urine is not sweet (insipidus meaning "without taste" in Latin); it can be caused by either kidney (nephrogenic DI) or pituitary gland (central DI) damage. It is a noninfectious disease. Among the body systems affected are the nerve, digestive, circulatory, endocrine and urinary systems.

The World Health Organization projects that the number of diabetics will exceed 350 million by 2030. Governments and other healthcare providers around the world are investing in health education, diagnosis and treatments for this chronic, debilitating - but controllable - disorder

The term "type 1 diabetes" has universally replaced several former terms, including childhood-onset diabetes, juvenile diabetes, and insulin-dependent diabetes mellitus (IDDM). Likewise, the term "type 2 diabetes" has replaced several former terms, including adult-onset diabetes, obesity-related diabetes, and non-insulin-dependent diabetes mellitus (NIDDM). Beyond these two types, there is no agreed-upon standard nomenclature. Various sources have defined "type 3 diabetes" as, among others, gestational diabetes,^[6] insulin-resistant type 1 diabetes (or "double diabetes"), type 2 diabetes which has progressed to require injected insulin, and latent autoimmune diabetes of adults (or LADA or "type 1.5" diabetes.^[7]) There is also maturity onset diabetes of the young (MODY) which is a group of several single gene (monogenic) disorders with strong family histories that present as type 2 diabetes before 30 years of age.

Type 1 diabetes

Diabetes mellitus type 1 (type I diabetes, T1D, T1DM, IDDM, juvenile diabetes) is a form of diabetes mellitus. Type 1 diabetes is anautoimmune disease ^[1] that results in destruction of insulin-producing beta cells of the pancreas. Lack of insulin causes an increase of fasting blood glucose (around 70-120 mg/dL in nondiabetic people) that begins to appear in the urine above the renal threshold (about 190-200 mg/dl in most people), thus connecting to the symptom by which the disease was identified in antiquity, sweet urine. Glycosuria or glucose in the urine causes the patients to urinate more frequently, and drink more than normal (polydipsia). Classically, these were the characteristic symptoms which prompted discovery of the disease.

Type 1 is lethal unless treated with exogenous insulin. Injection is the traditional and still most common method for administering insulin; jet injection, indwelling catheters, and inhaled insulin has also been available at various times, and there are several experimental methods as well. All replace the missing hormone formerly produced by the now non-functional beta cells in the pancreas. In recent years, pancreas transplants have also been used to treat type 1 diabetes. Islet cell transplant is also being investigated and has been achieved in mice and rats, and in experimental trials in humans as well^[2]. Use of stem cells to produce a new population of functioning beta cells seems to be a future possibility, but has yet to be demonstrated even in laboratories as of 2008.

Type 1 diabetes (formerly known as "childhood", "juvenile" or "insulin-dependent" diabetes) is not exclusively a childhood problem; the adult incidence of type 1 is noteworthy — many adults who contract type 1 diabetes are misdiagnosed with type 2 due to confusion on this point.

There is currently no clinically useful preventive measure against developing type 1 diabetes, though a vaccine has been proposed and anti-antibody approaches are also being investigated. Most people who develop type 1 were otherwise healthy and of a healthy weight on onset, but they can lose weight quickly and dangerously, if not promptly diagnosed. Although the cause of type 1 diabetes is still not fully understood, and diet and exercise may help, the immune system damage is characteristic of type 1.

The most definite laboratory test to distinguish type 1 from type 2 diabetes is the C-peptide assay, which is a measure of endogenous insulin production since external insulin has not (to date) included C-peptide. The presence of anti-islet antibodies (to Glutamic Acid Decarboxylase, Insulinoma Associated Peptide-2 or insulin), or lack of insulin resistance, determined by a glucose tolerance test, would also be suggestive of type 1. Many type 2 diabetics continue to produce insulin internally, and all have some degree of insulin resistance.

Testing for GAD 65 antibodies has been proposed as an improved test for differentiating between type 1 and type 2 diabetes as it appears that the immune system malfunction is connected with their presence
Pathophysiology

The cause of type 1 diabetes is still not fully understood. Some theorize that type 1 diabetes is generally a virally triggered autoimmune response in which the immune system's attack on virus infected cells is also directed against the beta cells in the pancreas. The autoimmuneattack may be triggered by reaction to an infection, for example by one of the viruses of the Coxsackie virus family or German measles, although the evidence is inconclusive. In type 1, pancreatic beta cells in the Islets of Langerhans are destroyed or damaged sufficiently to effectively abolish endogenous insulin production. This etiology distinguishes type 1's origin from type 2. It should also be noted that the use of insulin in treating a patient does not mean that patient has type 1 diabetes; the type of diabetes a patient has is determined only by the cause -- fundamentally by whether the patient is insulin resistant (type 2) or insulin deficient without insulin resistance (type 1).

This vulnerability is not shared by everyone, for not everyone infected by the suspected organisms develops type 1 diabetes. This has suggested presence of a genetic vulnerability^[3] and there is indeed an observed inherited tendency to develop type 1. It has been traced to particular HLA genotypes, though the connection between them and the triggering of an auto-immune reaction is still poorly understood.

Some researchers believe that the autoimmune response is influenced by antibodies against cow's milk proteins.^[4] A large retrospective controlled study published in 2006 strongly suggests that infants who were never breastfed had a risk for developing type 1 diabetes twice that of infants who were breastfed for at least three months.^{[citation needed]} The mechanism is not fully understood. No connection has been established between autoantibodies, antibodies to cow's milk proteins, and type 1 diabetes. A subtype of type 1 (identifiable by the presence of antibodies against beta cells) typically develops slowly and so is often confused with type 2. In addition, a small proportion of type 1 cases have the hereditary condition maturity onset diabetes of the young(MODY) which can also be confused with type 2.

Vitamin D in doses of 2000 IU per day given during the first year of a child's life has been connected in one study in Northern Finland (where intrinsic production of Vitamin D is low due to low natural light levels) with an 80% reduction in the risk of getting type 1 diabetes later in life. The causal connection, if any, is obscure.

Some suggest that deficiency of Vitamin D₃ (one of several related chemicals with Vitamin D activity) may be an important pathogenic factor in type 1 diabetes independent of geographical latitude, and so of available sun intensity.^{[citation needed]}

Some chemicals and drugs preferentially destroy pancreatic cells. Vacor (N-3-pyridylmethyl-N'-p-nitrophenyl urea), a rodenticide introduced in the United States in 1976, selectively destroys pancreatic beta cells, resulting in type 1 diabetes after accidental or intentional ingestion. Vacor was withdrawn from the U.S. market in 1979, but is still used in some countries. Zanosar is the trade name for streptozotocin, an antibiotic and antineoplastic agent used in chemotherapy for pancreatic cancer; it also kills beta cells, resulting in loss of insulin production. Other pancreatic problems, including trauma, pancreatitis or tumors (either malignant or benign), can also lead to loss of insulin production.

The exact cause(s) of type 1 diabetes are not yet fully understood, and research on those mentioned, and others, continues.

In December 2006, researchers from Toronto Hospital for Sick Children published research that shows a link between type 1 diabetes and the immune and nervous system. Using mice, the researchers discovered that a control circuit exists between insulin-producing cells and their associated sensory (pain-related) nerves.^[5] It's being suggested that faulty nerves in the pancreas could be a cause of type 1 diabetes

Inheritance

Type 1 Diabetes is a polygenic disease, meaning many different genes contribute to its expression. Depending on locus or combination of loci, it can be dominant, recessive, or somewhere in between. The strongest gene, IDDM1, is located in the MHC Class II region on chromosome 6, at staining region 6p21. This is believed to be responsible for the histocompatibility disorder characteristic of type 1: Insulin-producing pancreas cells (beta cells) display improper antigens to T Cells. This eventually leads to the production of antibodies that attack these beta cells. Weaker genes are also located on chromosomes 11 and 18.

Environmental factors can strongly influence expression of type 1. A study showed that for identical twins, when one twin had type 1 diabetes, the other twin only had type 1 30-50% of the time. Despite having the exact same genome, one twin had the disease, where the other did not; this shows that environmental factors, in addition to genetic factors, can influence disease prevalence. ^[6]

^{Inheritance

Type 1 Diabetes is a polygenic disease, meaning many different genes contribute to its expression. Depending on locus or combination of loci, it can be dominant, recessive, or somewhere in between. The strongest gene, IDDM1, is located in the MHC Class II region on chromosome 6, at staining region 6p21. This is believed to be responsible for the histocompatibility disorder characteristic of type 1: Insulin-producing pancreas cells (beta cells) display improper antigens to T Cells. This eventually leads to the production of antibodies that attack these beta cells. Weaker genes are also located on chromosomes 11 and 18.
Environmental factors can strongly influence expression of type 1. A study showed that for identical twins, when one twin had type 1 diabetes, the other twin only had type 1 30-50% of the time. Despite having the exact same genome, one twin had the disease, where the other did not; this shows that environmental factors, in addition to genetic factors, can influence disease prevalence. ^[6]
^Treatment
Main article: Diabetes management

Type 1 is treated with insulin replacement therapy — usually by insulin injection or insulin pump, along with attention to dietary management, typically including carbohydrate tracking, and careful monitoring of blood glucose levels using Glucose meters. Today the most common insulins are produced using genetic recombination techniques; formerly, cattle or pig insulins were used, and even sometimes insulin from fish. Major suppliers include Eli Lilly and Company, Novo-Nordisk, and Sanofi-Aventis. A more recent trend, from several suppliers, is insulin analogs which are slightly modified insulins which have different onset of action times or duration of action times.
Untreated type 1 diabetes commonly leads to coma, often from diabetic ketoacidosis, which is fatal if untreated. At present, insulin treatment must be continued for life; this may perhaps change if better treatment, or a cure, becomes clinically available. Continuous glucose monitors have been developed and marketed which can alert patients to the presence of dangerously high or low blood sugar levels, but the general lack of widespread insurance coverage (certainly in the US) and technical limitations has limited the impact these devices have had on clinical practice so far.
In more extreme cases, a pancreas transplant can restore proper glucose regulation. However, the surgery and accompanying immunosuppression required is considered by many physicians to be more dangerous than continued insulin replacement therapy, and is therefore often used only as a last resort (such as when a kidney must also be transplanted, or in cases where the patient's blood glucose levels are extremely volatile). Experimental replacement of beta cells (by transplant or from stem cells) is being investigated in several research programs and may become clinically available in the future. Thus far, beta cell replacement has only been performed on patients over age 18, and with tantalizing successes amidst nearly universal failure.

[edit]Pancreas transplantation
Main article: Pancreas transplantation
Pancreas transplants are generally performed together with or some time after a kidney transplant. One reason for this is that introducing a new kidney requires takingimmunosuppressive drugs anyway, and this allows the introduction of a new, functioning pancreas to a patient with diabetes without any additional immunosuppressive therapy. However, pancreas transplants alone can be wise in patients with extremely labile type 1 diabetes mellitus.^[7]

[edit]Islet cell transplantation
Main article: Islet cell transplantation
Islet cell transplantation is expected to be less invasive than a pancreas transplant which is currently the most commonly used approach in humans.
In one variant of this procedure, islet cells are injected into the patient's liver, where they take up residence and begin to produce insulin. The liver is expected to be the most reasonable choice because it is more accessible than the pancreas, and islet cells seem to produce insulin well in that environment. The patient's body, however, will treat the new cells just as it would any other introduction of foreign tissue, unless a method is developed to produce them from the patient's own stem cells or there is an identical twin available who can donate stem cells. The immune system will attack the cells as it would a bacterial infection or a skin graft. Thus, patients now also need to undergo treatment involving immunosuppressants, which reduce immune system activity.
Recent studies have shown that islet cell transplants have progressed to the point that 58% of the patients in one study were insulin independent one year after islet cell transplant.^[8] Ideally, it would be best to use islet cells which will not provoke this immune reaction, but scientists in New Zealand are also looking into placing them within a protective housing derived of sea-weed which enables insulin to flow out and nutrients to flow in while protecting the islets from immune system attack via white blood cells.

[edit]Prevalence
It is estimated that about 5%–10% of North American diabetes patients have type 1. The fraction of type 1 in other parts of the world differs; this is likely due to both differences in the rate of type 1 and differences in the rate of other types, most prominently type 2. Most of this difference is not currently understood. Variable criteria for categorizing diabetes types may play a part. Some notable people with type 1 are American football quarterback Jay Cutler, swimmer Gary Hall, Jr. and Nick Jonas.

[edit]Research foundations
The Juvenile Diabetes Research Foundation (JDRF) is the major charitable organization in the USA and Canada devoted to type 1 diabetes research. JDRF's mission is to cure type 1 diabetes and its complications through the support of research. Since its founding in 1970, JDRF has contributed more than $1.3 billion to diabetes research, including more than $156 million in FY 2008. In FY 2008, the Foundation funded 1,000 centers, grants and fellowships in 22 countries. In November 2008 JDRF launched a new online social network for people with type 1 diabetes--*Juvenation.
The International Diabetes Federation is a worldwide alliance of over 160 countries to address diabetes research and treatment. The American Diabetes Association funds some work on type 1 but devotes much of its resources to type 2 diabetes due to the increasing prevalence of the latter type. Diabetes Australia is involved in promoting research and education in Australia on both type 1 and type 2 diabetes. The Canadian Diabetes Association is also involved in educating, researching, and sustaining sufferers of type 1 Diabetics in Canada. Pacific Northwest Diabetes Research Institute conducts clinical and basic research on type 1 and type 2 diabetes.

[edit]Cure
As of 2009, there is no known cure for diabetes mellitus type 1 in modern clinical use. Pancreas transplant is not practical (too few are available, and pancreas transplant is technically difficult. The requirement for immuno-suppressive drugs contributes to the unsatisfactory nature of pancreas transplant as a cure). Nor is a cure known from any other source including traditional or alternative medical practice. There is ongoing research on various approaches to curing diabetes type 1.
Diabetes type 1 is caused by the destruction of enough beta cells to produce symptoms; these cells, which are found in the Islets of Langerhans in the pancreas, produce and secrete insulin, the single hormone responsible for allowing glucose to enter from the blood into cells (in addition to the hormone amylin, another hormone required for glucosehomeostasis). Hence, the phrase "curing diabetes type 1" means "causing a maintenance or restoration of the endogenous ability of the body to produce insulin in response to the level of blood glucose" and cooperative operation with counterregulatory hormones.
This section deals only with approaches for curing the underlying condition of diabetes type 1, by enabling the body to endogenously, in vivo, produce insulin in response to the level of blood glucose. It does not cover other approaches, such as, for instance, closed-loop integrated glucometer/insulin pump products, which could potentially increase the quality-of-life for some who have diabetes type 1, and may by some be termed "artificial pancreas".}

Reversion Encapsulation approach

A biological approach to the artificial pancreas is to implant bioengineered tissue containing islet cells, which would secrete the amounts of insulin, amylin and glucagon needed in response to sensed glucose.

When islet cells have been transplanted via the Edmonton protocol, insulin production (and glycemic control) was restored, but at the expense of continued immunosuppression drugs. Encapsulation of the islet cells in a protective coating has been developed to block the immune response to transplanted cells, which relieves the burden of immunosuppression and benefits the longevity of the transplant.^[9]

One concept of the bio-artificial pancreas uses encapsulated islet cells to build an islet sheet which can be surgically implanted to function as an artificial pancreas.^[10]

This islet sheet design consists of:

an inner mesh of fibers to provide strength for the islet sheet;
islet cells, encapsulated to avoid triggering a proliferating immune response, adhered to the mesh fibers;
a semi-permeable protective layer around the sheet, to allow the diffusion of nutrients and secreted hormones;
a protective coating, to prevent a foreign body response resulting in a fibrotic reaction which walls off the sheet and causes failure of the islet cells.

Islet sheet with encapsulation research is pressing forward with large animal studies at the present, with plans for human clinical trials within a few years.

Clinical studies underway in New Zealand by Living Cell Technologies have encapsulated pig islet cells in a sea-weed derived capsule. This approach has had very positive clinical studies and is currently underway in human trials as of 2008. So far, treatment using this method of cell encapsulation has been proven safe and effective and is the first to achieve insulin independence in human trials without immunosupressant drugs.^[11]

Islet cell regeneration approach

Research undertaken at the Massachusetts General Hospital between 2001 and 2003 demonstrated a protocol to reverse type 1 diabetes in non-obese diabetic mice (a frequently used animal model for type 1 diabetes mellitus).^[12] Three other institutions have had similar results, as published in the March 24, 2006 issue of Science. A fourth study by the National Institutes of Health achieved similar results, and also sheds light on the biological mechanisms involved.^[13]

Other researchers, most notably Dr. Aaron I. Vinik of the Strelitz Diabetes Research Institute of Eastern Virginia Medical School and a former colleague, Dr. Lawrence Rosenberg (now at McGill University) discovered in a protein they refer to as INGAP, which stands for Islet Neogenesis Associated Protein back in 1997. INGAP seems to be the product of a gene responsible for regenerating the islets that make insulin and other important hormones in the pancreas.

INGAP has had commercialization difficulties. Although it has appeared promising, commercial rights have changed hands repeatedly, having once been owned by Procter & Gamble Pharmaceuticals, which eventually dropped it. Rights were then acquired by GMP Companies. More recently, Kinexum Metabolics, Inc. has since sublicensed INGAP from GMP for further clinical trials. Kinexum has continued development under Dr. G. Alexander Fleming, an experienced metabolic drug developer, who headed diabetes drug review at the FDA for over a decade. As of 2008, the protein had undergone Phase 2 Human Clinical Trials, and developers were analyzing the results. At the American Diabetes Association's 68th Annual Scientific Sessions in San Francisco, Kinexum announced a Phase 2 human clinical trial with a combination therapy, consisting of DiaKine's Lisofylline (LSF) and Kinexum's INGAP peptide, which is expected to begin in late 2008.^[14] The trial will be unique in that patients who are beyond the 'newly diagnosed' period will be included in the study. Most current trials seeking to treat people with type 1 diabetes do not include those with established disease.

Stem cells approach

Research is being done at several locations in which islet cells are developed from stem cells.

South Korea

In January 2006, a team of South Korean scientists has grown pancreatic beta cells, which can help treat diabetes, from stem cells taken from the umbilical cord blood of newborn babies.

Brazil

In April 2007, it was reported by the Times Online that 15 young Brazilian patients diagnosed with type 1 diabetes were able to naturally produce insulin once again after undergoing mild chemotherapy to temporarily weaken their immune systems and then injection of their own stem cells. This allowed the pancreatic beta cells to produce insulin. Since white blood cells were blocking the pancreas from producing insulin, Dr. Voltarelli and colleagues killed the immune cells, allowing the pancreas to secrete insulin once more.^[15]

However, there were no control subjects, which means that all of the processes could have been completely or partially natural. Secondly, no theory for the mechanism of cure has been promoted. It is too early to say whether the results will be positive or negative in the long run.^[16]

University of North Carolina

In September 2008, scientists from the University of North Carolina at Chapel Hill School of Medicine have announced their success in transforming cells from human skin into cells that produce insulin.^[17]

The skin cells were first transformed into stem cells and then had been differentiated into insulin-secreting cells.^[18]

However, other scientists have doubts, as the research papers fail to detail the new cells' glucose responsiveness and the amount of insulin they are capable of producing.

Islet cell regeneration approach

Stem cells approach

Research is being done at several locations in which islet cells are developed from stem cells.

South Korea

In January 2006, a team of South Korean scientists has grown pancreatic beta cells, which can help treat diabetes, from stem cells taken from the umbilical cord blood of newborn babies.

Brazil

University of North Carolina

The skin cells were first transformed into stem cells and then had been differentiated into insulin-secreting cells.^[18]

However, other scientists have doubts, as the research papers fail to detail the new cells' glucose responsiveness and the amount of insulin they are capable of producing.

Gene Therapy Approach

Technology for gene therapy is advancing rapidly such that there are multiple pathways possible to support endocrine function, with potential to practically cure diabetes.^[19]

Gene therapy can be used to manufacture insulin directly: an oral medication, consisting of viral vectors containing the insulin sequence, is digested and delivers its genes to the upper intestines. Those intestinal cells will then behave like any viral infected cell, and will reproduce the insulin protein. The virus can be controlled to infect only the cells which respond to the presence of glucose, such that insulin is produced only in the presence of high glucose levels. Due to the limited numbers of vectors delivered, very few intestinal cells would actually be impacted and would die off naturally in a few days. Therefore by varying the amount of oral medication used, the amount of insulin created by gene therapy can be increased or decreased as needed. As the insulin producing intestinal cells die off, they are boosted by additional oral medications.^[20]
Gene therapy might eventually be used to cure the cause of beta cell destruction, thereby curing the new diabetes patient before the beta cell destruction is complete and irreversible.^[21]
Gene therapy can be used to turn duodenum cells and duodenum adult stem cells into beta cells which produce insulin and amylin naturally. By delivering beta cell DNA to the intestine cells in the duodenum, a few intestine cells will turn into beta cells, and subsequently adult stem cells will develop into beta cells. This makes the supply of beta cells in the duodenum self replenishing, and the beta cells will produce insulin in proportional response to carbohydrates consumed.^[22]

Yonsei University

Scientists in the South Korean university of Yonsei have, in 2000, succeeded in reversing diabetes in mice and rats. Using a viral vector, a DNA encoding the production of an insulin analog was injected to the animals, which remained non-diabetic for at least the eight months duration of the study.^[23]

Prevention

"Immunization" approach

If a biochemical mechanism can be found that prevents the immune system from attacking beta cells, it may be administered to prevent commencement of diabetes type 1. Several groups are trying to achieve this by causing the activation state of the immune system to change from Th1 state (“attack” by killer T Cells) to Th2 state (development of new antibodies). This Th1-Th2 shift occurs via a change in the type of cytokine signaling molecules being released by regulatory T-cells. Instead of pro-inflammatory cytokines, the regulatory T-cells begin to release cytokines that inhibit inflammation.^[24] This phenomenon is commonly known as "acquired immune tolerance".

DiaPep277

A substance designed to cause lymphocyte cells to cease attacking beta cells, DiaPep277 is a peptide fragment of a larger protein called HSP60. Given as a subcutaneous injection, its mechanism of action involves a Th1-Th2 shift. Clinical success has been demonstrated in prolonging the "honeymoon" period for people who already have type 1 diabetes.^[25] The product is currently being tested in people with latent autoimmune diabetes of adults (LADA). Ownership of the drug has changed hands several times over the last decade. In 2007, Clal Biotechnology Industries (CBI) Ltd., an Israeli investment group in the field of life sciences, announced that Andromeda Biotech Ltd., a wholly owned subsidiary of CBI, signed a Term Sheet with Teva Pharmaceutical Industries Ltd. to develop and commercialize DiaPep277.^[26]

Intra-nasal insulin

There is pre-clinical evidence that a Th1-Th2 shift can be induced by administration of insulin directly onto the immune tissue in the nasal cavity. This observation has led to a clinical trial, called INIT II, which began in late 2006, based in Australia and New Zealand.

BCG research

Tumor necrosis factor-alpha, or TNF-a, is part of the immune system. It helps the immune system distinguish self from non-self tissue. People with type 1 diabetes are deficient in this substance. Dr. Denise Faustman theorizes that giving Bacillus Calmette-Guérin (BCG), an inexpensive generic drug, would have the same impact as injecting diabetic mice with Freund's Adjuvant, which stimulates TNF-a production. TNF-a kills the white blood cells responsible for destroying beta cells, and thus prevents, or reverses diabetes.^[27] She has reversed diabetes in laboratory mice with this technique, but was only able to receive funding for subsequent research from The Iaccoca Foundation, founded by Lee Iacocca in honor of his late wife, who died from diabetes complications. Human trials are set to begin in 2008.

Diamyd

Diamyd is the name of a vaccine being developed by Diamyd Medical. Injections with GAD65, an autoantigen involved in type 1 diabetes, has in clinical trials delayed the destruction of beta cells for at least 30 months, without serious adverse effects. Patients treated with the substance showed higher levels of regulatory cytokines, thought to protect the beta cells.^[28] Phase III trials are under way in the USA ^[29] and in Europe^[30].^[31]^[32] Two prevention studies, where the vaccine is given to persons who have not yet developed diabetes, will start in 2009^[33]^[34].

Entities involved in research

This section is an incomplete list of mainly commercial companies but also other entities, namely governmental institutions and individual persons, actively involved in research towards finding a cure to diabetes type 1.
It does not list research funds, hospitals in which research is undertaken, etc., but only the industrious, actual developers of such products.

Entities are listed alphabetically along with their status of research in that field, so that also entities which ceased research into finding a cure to diabetes type 1 may be listed.

Amylin Pharmaceuticals – is working toward finding a cure, and has a drug on the market called Symlin (pramlintide acetate) that helps in treating Type 1 diabetes
Cerco Medical [1] – Present status: Unknown
Denise Faustman [2] – Present status: Working on immune modification
DeveloGen [3] – Present status: Developing DiaPep 277
Diamyd Medical [4] – Present status: Developing GAD65-based vaccine (phase III trial started)
Tolerx, Inc. [www.defendagainstdiabetes.com] - Present status: Now (4/2009) in Phase 3 clinical study of otelixizumab, an Fc-disabled, anti-CD3 monoclonal antibody in patients with new onset (diagnosis within last 10 weeks) type 1 diabetes.

References

^ ""Type 1 Diabetes Mellitus"". Retrieved on 2008-08-04.
^ ""One Step Closer to a Cure - Interview; Patrick Perry, Saturday Evening Post"". Retrieved on 2008-11-02.
^ "Donner", "Horst"; "Harald Rau, Paul G. Walfish, Jens Braun, Thorsten Siegmund, Reinhard Finke, Jürgen Herwig, Klaus H. Usadel and Klaus Badenhoop" ("2007"). ""CTLA4 Alanine-17 Confers Genetic Susceptibility to Graves’ Disease and to Type 1 Diabetes Mellitus"". "The Journal of Clinical Endocrinology & Metabolism Vol. 82, No. 1 143-146". "The Journal of Clinical Endocrinology & Metabolism". Retrieved on 2008-02-06.
^ content.nejm.org
^ "Canadian scientists reverse diabetes in mice". Retrieved on 2007-06-04.
^ http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=222100
^ Pancreas Transplantation: Indications and Consequences
^ "Islet cell transplant: Experimental treatment for type 1 diabetes - MayoClinic.com". Retrieved on 2007-06-04.
^ Cerco Medical: Science: Methods
^ Cerco Medical: Company: Islet Sheet Research
^ Living Cell Technologies web site: Diabecell
^ "November 13, 2003 Regeneration of insulin-producing islets may lead to diabetes cure". Retrieved on 2007-06-04.
^ Faustman DL, Tran SD, Kodama S, et al (2006). "Comment on papers by Chong et al., Nishio et al., and Suri et al. on diabetes reversal in NOD mice". Science 314 (5803): 1243; author reply 1243.doi:10.1126/science.1129811. PMID 17124308.
^ DiaKine Therapeutics and Kinexum Metabolics to Develop Novel Combination Treatment to Type 1 Diabetes
^ http://www.timesonline.co.uk/tol/comment/leading_article/article1637235.ece
^ Voltarelli JC, Couri CE, Stracieri AB, et al (2007). "Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus". JAMA 297 (14): 1568–76.doi:10.1001/jama.297.14.1568. PMID 17426276.
^ http://www.eurekalert.org/pub_releases/2008-09/uonc-ust091708.php
^ http://www.jbc.org/cgi/content/abstract/M806597200v1
^

Web Directory Listings of the top sites in each category.

Blog Web Discovery Machine

More News LINKS

NEWS SOURCES

BLOGS

COLUMNISTS

ALL THINGS ARIANNA

[edit]Pancreas transplantation

[edit]Islet cell transplantation

[edit]Prevalence

[edit]Research foundations

[edit]Cure

Islet cell regeneration approach

Stem cells approach

South Korea

Brazil

University of North Carolina

Islet cell regeneration approach

Stem cells approach

South Korea

Brazil

University of North Carolina

Yonsei University

Prevention

"Immunization" approach

DiaPep277

Intra-nasal insulin

BCG research

Diamyd

Entities involved in research

See also

Further reading

References